Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

137.74USD
21 Jul 2017
Change (% chg)

$1.43 (+1.05%)
Prev Close
$136.31
Open
$136.23
Day's High
$138.17
Day's Low
$135.72
Volume
3,651,611
Avg. Vol
3,741,042
52-wk High
$138.17
52-wk Low
$96.93

KARSEN PERRY A

Institutional Holders

% Shares Owned: 80.31%
# of Holders: 1,864
Total Shares Held: 627,103,729
3 Mo. Net Change: 1,116,567
# New Positions: 18
# Closed Positions: 16
# Increased Positions: 148
# Reduced Positions: 119
# Net Buyers: 29

Officers & Directors

Name Age Since Current Position

Robert Hugin

62 2016 Executive Chairman of the Board

Scott Smith

55 2017 President, Chief Operating Officer

Mark Alles

58 2016 Chief Executive Officer, Director

Peter Kellogg

61 2014 Chief Financial Officer, Executive Vice President

Terrie Curran

48 2017 President, Global Inflammation & Immunology Franchise

Michael Pehl

52 2016 President, Hematology & Oncology

Rupert Vessey

52 2016 President - Research and Early Development

Gerald Masoudi

49 Executive Vice President, General Counsel and Corporate Secretary

Michael Casey

71 2007 Lead Independent Director

Michael Bonney

58 2015 Director

Julia Haller

62 2015 Director

Richard Barker

68 2012 Independent Director

Carrie Cox

59 2009 Independent Director

Michael Friedman

73 2011 Independent Director

Gilla Kaplan

70 1998 Independent Director

James Loughlin

74 2007 Independent Director

Ernest Mario

78 2007 Independent Director